Terazosin hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68788-9817 -
Package NDC
68788-9817-1 -
Package NDC
68788-9817-3 -
Package NDC
68788-9817-6 -
Package NDC
68788-9817-9 -
Application number
ANDA075317 -
SPL ID
22a5c8ce-fac9-4cca-ad67-a7dff1c9203e -
SPL set ID
9d8fd052-b478-447e-a884-74fcd21275bb -
UNII
D32S14F082 -
RxCUI
313215 -
RxCUI
313217 -
RxCUI
313219
What the source publishes
- Labeler
- Preferred Pharmaceuticals, Inc
- Active ingredients
- Terazosin hydrochloride
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Terazosin hydrochloride",
"splId": "22a5c8ce-fac9-4cca-ad67-a7dff1c9203e",
"labels": [
{
"setId": "9d8fd052-b478-447e-a884-74fcd21275bb",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9d8fd052-b478-447e-a884-74fcd21275bb",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9d8fd052-b478-447e-a884-74fcd21275bb"
}
],
"routes": [
"ORAL"
],
"labeler": "Preferred Pharmaceuticals, Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE in 1 BOTTLE (68788-9817-1)",
"package_ndc": "68788-9817-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20120405"
},
{
"sample": false,
"description": "30 CAPSULE in 1 BOTTLE (68788-9817-3)",
"package_ndc": "68788-9817-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20120405"
},
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE (68788-9817-6)",
"package_ndc": "68788-9817-6",
"identifierStatus": "well-formed",
"marketing_start_date": "20120405"
},
{
"sample": false,
"description": "90 CAPSULE in 1 BOTTLE (68788-9817-9)",
"package_ndc": "68788-9817-9",
"identifierStatus": "well-formed",
"marketing_start_date": "20120405"
}
],
"productId": "68788-9817_22a5c8ce-fac9-4cca-ad67-a7dff1c9203e",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "68788-9817",
"deaSchedule": null,
"genericName": "Terazosin hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TERAZOSIN HYDROCHLORIDE",
"strength": "1 mg/1"
}
],
"applicationNumber": "ANDA075317",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120405",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"D32S14F082"
],
"rxcui": [
"313215",
"313217",
"313219"
],
"spl_set_id": [
"9d8fd052-b478-447e-a884-74fcd21275bb"
],
"manufacturer_name": [
"Preferred Pharmaceuticals, Inc"
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68788-9817_22a5c8ce-fac9-4cca-ad67-a7dff1c9203e"